Additional Information
- Side Effects of Bextra
- Timeline of Events
has the experience
and resources to
handle complex claims involving prescription medication.
Timeline of Events
November 2001 - Bextra is approved by the United States Food and Drug Administration for treatment of osteoarthritis, menstrual pain, and acute pain in adults.
November 2004 – A key Cox-2 researcher is asked to leave an FDA panel after he finds that Bextra doubles the risk of heart attacks and strokes.
December 2004 - The New England Journal of Medicine states that Bextra increased the risk of serious cardiovascular outcomes (heart attacks and strokes) by a factor of approximately three.
January 2005 -- Public Citizen consumer group issues petitions to remove Bextra.
February 2005 - New England Journal of Medicine article states the use of Bextra after bypass surgery was associated with an increased incident of cardiovascular events (heart attack and stroke).
February 2005 - CBSnews.com cites a new study indicating Bextra increases the risk of heart attack and stroke by 50% .
April 2005 - Bextra is withdrawn from the market by the FDA